Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

Anniina Koski(University of Helsinki), Lotta Kangasniemi(Oncos Therapeutics (Finland)), Sophie Escutenaire(University of Helsinki), Sari Pesonen(University of Helsinki), Vincenzo Cerullo(University of Helsinki), Iulia Diaconu(University of Helsinki), Petri Nokisalmi(University of Helsinki), Mari Raki(University of Helsinki), Maria Rajecki(University of Helsinki), Kilian Guse(University of Helsinki), Tuuli Ranki(University of Helsinki), Minna Oksanen(University of Helsinki), Liisa Holm(University of Helsinki), Elina Haavisto(Oncos Therapeutics (Finland)), Aila Karioja‐Kallio(Oncos Therapeutics (Finland)), Leena Laasonen(University of Helsinki), Kaarina Partanen(Docrates Cancer Center), Matteo Ugolini(University of Helsinki), Andreas Helminen(Docrates Cancer Center), Eerika Karli(University of Helsinki), Päivi Hannuksela(University of Helsinki), Saila K. Pesonen(University of Helsinki), Timo Joensuu(Docrates Cancer Center), Anna Kanerva(University of Helsinki), Akseli Hemminki(University of Helsinki)
Molecular Therapy
July 27, 2010
10.1038/mt.2010.161
Cited by 250Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis